top of page


Three Years, Twelve Thousand Lives Reached: Dexa Group Expands Access to Free Health Screenings
Bandung — Dexa Group continues to expand public access to early detection and health education through its Cek Segitiga: Free Health Screening program. Now entering its third year, this initiative, organized through Dharma Dexa, has reached more than 12,000 people across various cities in Indonesia. During its latest event at GOR Saparua, Bandung, on Sunday (May 10, 2026), Dexa Group collaborated with Santo Yusup Hospital to provide free health screenings for 602 residents. O
May 12


Expression of Gratitude and Dedication to Health: Dharma Dexa Holds Cataract Surgery in Kupang Region
As a form of gratitude towards Dexa Group’s 55-year journey and to demonstrate dedication to the health sector, Dexa Group, through Dharma Dexa, organized a cataract surgery social service for the community in Kupang. This social service was conducted in collaboration with RSUP dr. Ben Mboi on Tuesday, July 23, 2024, in Kupang, East Nusa Tenggara. Residents showed enthusiasm from early morning as they gathered for the cataract surgery. They traveled outside Kupang, including
Jul 31, 2024


Enhancing Health Promotion and Prevention, Dharma Dexa Partners Up with RS Abdi Waluyo to Provide Free Health Screenings and Consultations for Hypertension, Cholesterol, and Diabetes
In alignment with the governmental health transformation initiative, PT Dexa Medica, through its Corporate Social Responsibility initiative, Dharma Dexa, invites people to partake in a chronic disease screening initiative named “Cek Segitiga.” This campaign underscores the importance of health screenings. “PT Dexa Medica is spearheading the ‘Cek Segitiga’ initiative, facilitating tests for hypertension, cholesterol, and diabetes across six cities to offer free health examinat
Jul 23, 2024


Ferron Partners with PERKENI for 2024 CVM Summit and Unveils New Diabetes Treatment
PT Ferron Par Pharmaceuticals, in collaboration with the Indonesian Society of Endocrinology (PERKENI), held the Cardio-Vascular Metabolic (CVM) Summit titled “1st Ferron CVM Summit.” During the event, Ferron launched its latest anti-diabetes product, Fliptin. The event was attended by Dexa Group CEO, Mr. Ferry Soetikno; Dexa Group President Commissioner, Mrs. Gracianti Soetikno; Molecular Pharmacologist and also Dexa Group’s Business Development and Scientific Affairs Direct
Jul 8, 2024
bottom of page